Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Track all the latest updates and news of Parabolic Drugs IPO.
March 29, 2024 3:30:00 AM
An IPO could happen as early as late July as the company looks to cash in on investor excitement about the next generation of weight-loss drugs and a revival in the biotech IPO market. A total of ...
Published by : The Financial TimesMarch 28, 2024 10:40:00 AM
An investigational new drug application for a third program isn't expected to be filed until the first half of 2026. Boundless isn�t the only biotech IPO set for spring. Contineum Therapeutics ...
Published by : FierceBiotechApril 4, 2024 3:30:00 AM
By this time last year, only four drug startups had gone public, raising $375 million. In 2022, nine companies had pulled in $744 million. The IPO activity has been accompanied by a step-up in ...
Published by : Yahoo FinanceMarch 28, 2024 4:45:00 PM
The company has developed a diagnostic to identify patients amenable to treatment with an ecDNA-directed drug. In the IPO filing, the company said it is working with an in vitro diagnostic company ...
Published by : MedCity NewsApril 9, 2024 10:52:00 PM
Super Micro's 17-Year Run Super Micro Computer went public in March 2007, pricing its IPO at $8 per share ... Micro shares have delivered essentially parabolic returns for investors as demand ...
Published by : U.S. News & World ReportMarch 21, 2024 11:41:00 PM
Shares of social forum giant Reddit closed its first day of trading at $50.31, up nearly 48% from its IPO price of $34 per share. The company had indicated a target range of $31 to $34 per share ...
Published by : TechCrunchMarch 21, 2024 2:07:00 AM
Reddit priced its initial public offering at the high end of its targeted range, a sign that investor enthusiasm could be returning for new issues. Reddit, set to debut Thursday under the ticker ...
Published by : Wall Street JournalMarch 21, 2024 8:52:00 PM
The reception is a positive indicator for the social media sector, which has been experiencing an IPO dry spell. Founded in 2005 by web developer Steve Huffman and entrepreneur Alexis Ohanian ...
Published by : Fox BusinessMarch 23, 2024 6:40:00 AM
Shares of the social media company soared on its Big Board debut under the ticker RDDT, closing at $50.44, or 48 percent above its IPO price. This brought its fully diluted market capitalization ...
Published by : Ars TechnicaIPO Listing Detail
Listing Date: Thursday, July 01, 2010
BSE Scrip Code: 533211
NSE Symbol: PARABOLIC
Listing In: 'B' Group of Securities
ISIN: INE618H01016
Issue Price: Rs. 75.00 Per Equity Share
Face Value: Rs. 10.00 Per Equity Share
Parabolic Drugs Ltd IPO allotment status is now available online.
Parabolic Drugs IPO was open on Jun 14, 2010 and closed on Jun 17, 2010. IPO was oversubscribed by 1.04 times (0.4000 times in retail).
Parabolic Drugs Ltd IPO finally subscribed 1.04 times on its closing day. Parabolic Drugs Ltd IPO was open on Jun 14, 2010 and closed today on Jun 17, 2010 for subscription. Parabolic Drugs Ltd has received bids for 2,77,52,400 shares as against issue size of 2,66,66,667 shares.
Oversubscription detail
Qualified Institutional Buyers (QIBs): 1.48 Times
Non Institutional Investors: 1.20 Times
Retail Individual Investors (RIIs): 0.40 Times
Employee: 0.11 Times
Total: 1.04 Times
Parabolic Drugs Limited is entering in the capital markets with an initial public offering, IPO of Rs. 200 Crore. The price band for the issue has not been decided yet.
Incorporated in 1996, Parabolic Drugs Limited is in the business of manufacturing Active Pharmaceutical Ingredients (API's) and API intermediates. APIs, also known as 'bulk drugs' or 'bulk actives' are the principal ingredient used in making finished dosages in the form of capsules, tablets, liquid, or other forms of dosage, with the addition of other APIs or inactive ingredients.
The issue opens on Jun 14, 2010, and closes for subscription on Jun 17, 2010. The equity shares of the company are proposed to be listed on the Bombay Stock Exchange (BSE) and National Stock Exchange (NSE).
The Parabolic Drugs IPO is proposed to open on June 14, 2010. The IPO application ends on June 17, 2010.
Retail investors can apply in the retail or non-institutional investor category from June 14, 2010 to June 17, 2010. The Parabolic Drugs IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).
The Parabolic Drugs IPO will open for subscription on June 14, 2010. The public issue will close on June 17, 2010.
Useful Articles
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
RHP
